Lantern Pharma Stock (NASDAQ: LTRN) stock price, news, charts, stock research, profile.
Open | $4.10 |
Close | - |
Volume / Avg. | 28.89K / 56.69K |
Day Range | $3.95 - $4.25 |
52 Wk Range | 2.38 - 11.99 |
Market Cap | $42.90M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 50 |
Short Interest | 2.36% |
Days to Cover | 5.31 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Lantern Pharma (NASDAQ:LTRN) through any online brokerage.
Other companies in Lantern Pharma’s space includes: HOOKIPA Pharma (NASDAQ:HOOK), Kezar Life Sciences (NASDAQ:KZR), Estrella Immunopharma (NASDAQ:ESLA), OncoCyte (NASDAQ:OCX) and Gain Therapeutics (NASDAQ:GANX).
Lantern Pharma has a consensus price target of $11.00.
The stock price for Lantern Pharma (NASDAQ: LTRN) is $3.985 last updated September 23, 2024 at 10:47 AM EDT.
There are no upcoming dividends for Lantern Pharma.
Lantern Pharma’s Q3 earnings are confirmed for Wednesday, November 6, 2024.
There is no upcoming split for Lantern Pharma.
Lantern Pharma is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.